Русский
Nederlandse taal
Deutsch
Francés
한국어
Português
Español
日本語
ไทย
Fractional Mesotherapy Face
Ingredient: 12mg/ml Micro cross-linked Hyaluronic Acid, Amino acids, Carnosine, Vitamin B2, Lidocaine hydrochloride
Specification: 1ml, 2ml
Package: Single package, Sterile
Application Area: Face
Product Introduction：
The stability of micro-crosslinked sodium hyaluronate extends its effectiveness, preventing uneven texture while offering deep hydration and wrinkle reduction. Provides deep hydration and essential nourishment to the skin, leaving it glowing with a natural radiance. Formulated to enhance skin elasticity by replenishing the dermis with vital nutrients, effectively addressing signs of aging and sagging.
Product Display：
Product Details:
Type | Face Mesotherapy |
Specification | 1ml, 2ml |
Ingredients | Micro cross linked sodium hyaluronic 12mg/ml, amino acids, carnosine, vitamin B2, lidocaine hydrochloride |
Application | Dermis: firming up |
Function | Relieve skin dryness and dehydration, give skin natural shine, improve skin firmness |
Package | Single package, Sterile |
Storage | Room temperature (1-25ºC), cool and dry place |
Recommended | 1-2 pc |
Recommended interval | 1 time/month,3 months in a row |
Product Package:
Customer Feedback：
Raw Material Advantages：
Featuring enhanced crosslinking, micro-crosslinked sodium hyaluronate delivers long-lasting hydration and firmness, preventing surface irregularities and smoothing fine lines.
With a high concentration of sodium hyaluronate, the product provides more significant and longer-lasting results. Its exclusive micro-crosslinked formula prevents uneven texture, repairs fine lines, and ensures lasting effects. Lidocaine is included for a more comfortable experience.
Development Process:
Company Introduction:
Enriched by 15 years of experience in polysaccharide modification and crosslinking, our medical-grade material modification platform efficiently converts chitosan into carboxymethyl chitosan—illustrated by our marketed surgical anti-adhesion fluid—and transforms sodium hyaluronate into crosslinked sodium hyaluronate using advanced biphasic, monophasic, and micro-crosslinking techniques, while our microsphere fabrication technology produces crosslinked starch microspheres (integral to our composite microporous polysaccharide hemostatic powder) and innovative injectable PCL, PLLA, and PMMA microspheres via solvent-free and novel emulsification processes.
